> Back to JHP Titles
EMPLOYER INITIATIVES TO SUPPORT SMOKING CESSATION:
STRATEGIES FOR SUCCESS
Gregg M. Stave, MD, JD, MPH;
Riad Dirani, PhD; William B. Bunn, III, MD, JD, MPH
1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual
causes of death in the United States, 2000. JAMA. 2004;291:1238-1245.
2. Centers for Disease Control and Prevention. Annual smoking-attributable mortality,
years of potential life lost, and productivity losses--United States, 1997-2001.
MMWR Morb Mortal Wkly Rep. 2005;54:625-628.
3. Tsai SP, Wendt JK, Cardarelli KM, Fraser AE. A mortality and morbidity study
of refinery and petrochemical employees in Louisiana. Occup Environ Med. 2003;60:627-633.
4. Stewart WF, Ricci JA, Chee E, Morganstein D. Lost productive work time costs
from health conditions in the United States: results from the American Productivity
Audit. J Occup Environ Med. 2003;45:1234-1246.
5. Bunn WBI, Stave GM, Downs KE, Alvir JM, Dirani R. Effect of smoking status
on productivity loss. J Occup Environ Med. 2006;48:1099-1108.
6. Office of the US Surgeon General. The health consequences of involuntary exposure
to tobacco smoke: a report of the Surgeon General. Atlanta, Ga.: US Dept of Health
and Human Services; 2006.
7. Mannino DM, Siegel M, Rose D, Nkuchia J, Etzel R. Environmental tobacco smoke
exposure in the home and worksite and health effects in adults: results from
the 1991 National Health Interview Survey. Tob Control. 1997;6:296-305.
8. Eriksen MP, Gottlieb NH. A review of the health impact of smoking control
at the workplace. Am J Health Promot. 1998;13:83-104.
9. Stillman FA, Becker DM, Swank RT, et al. Ending smoking at the Johns Hopkins
Medical Institutions. An evaluation of smoking prevalence and indoor air pollution.
JAMA. 1990;264:1565-1569.
10. Centers for Disease Control and Prevention. Cigarette smoking among adults--United
States, 2004. MMWR Morb Mortal Wkly Rep. 2005;54:1121-1124.
11. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence
among untreated smokers. Addiction. 2004;99:29-38.
12. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation.
Cochrane Database Syst Rev. 2004;4:CD000031.
13. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy
for smoking cessation. Cochrane Database Syst Rev. 2004;3:CD000146.
14. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation.
Cochrane Database Syst Rev. 2005;CD001007.
15. Niaura R, Abrams DB. Smoking cessation: progress, priorities, and prospectus.
J Consult Clin Psychol. 2002;70:494-509.
16. Abrams DB, Orleans CT, Niaura RS, Goldstein MG, Prochaska JO, Velicer W.
Integrating individual and public health perspectives for treatment of tobacco
dependence under managed health care: a combined stepped care and matching model.
Ann Behav Med. 1996;18:290-304.
17. Centers for Disease Control and Prevention. Strategies for reducing exposure
to environmental tobacco smoke, increasing tobacco-use cessation, and reducing
initiation in communities and health-care systems. A report on recommendations
of the Task Force on Community Preventive Services. MMWR Recomm Rep. 2000;49:1-11.
18. Hey K, Perera R. Competitions and incentives for smoking cessation. Cochrane
Database Syst Rev. 2005;CD004307.
19. Sorensen G. Worksite tobacco control programs: the role of occupational health.
Respir Physiol. 2001;128:89-102.
20. Hopkins DP, Briss PA, Ricard CJ, et al. Reviews of evidence regarding interventions
to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev
Med. 2001;20:16-66.
21. Moher M, Hey K, Lancaster T. Workplace interventions for smoking cessation.
Cochrane Database Syst Rev. 2005;CD003440.
22. Orleans CS, Shipley RH. Worksite smoking cessation initiatives: review and
recommendations. Addict Behav. 1982;7:1-16.
23. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane
Database Syst Rev. 2005;CD001118.
24. Omenn GS, Thompson B, Sexton M, et al. A randomized comparison of Worksite-sponsored
smoking cessation programs. Am J Prev Med. 1988;4:261-267.
25. Katz DA, Muehlenbruch DR, Brown RL, Fiore MC, Baker TB. Effectiveness of
implementing the agency for healthcare research and quality smoking cessation
clinical practice guideline: a randomized, controlled trial. J Natl Cancer Inst.
2004;96:594-603.
26. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence:
Clinical practice guideline. Rockville, Md: US Dept of Health and Human Services,
Public Health Service; 2000:1-196.
27. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database
Syst Rev. 2004;CD000165.
28. Rose G, Hamilton PJ. A randomised controlled trial of the effect on middle-aged
men of advice to stop smoking. J Epidemiol Community Health. 1978;32:275-281.
29. Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners'
advice against smoking. Br Med J. 1979;2:231-235.
30. Lang T, Nicaud V, Slama K, et al. Smoking cessation at the workplace. Results
of a randomised controlled intervention study. Worksite physicians from the AIREL
group. J Epidemiol Community Health. 2000;54:349-354.
31. Kadowaki T, Watanabe M, Okayama A, Hishida K, Ueshima H. Effectiveness of
smoking-cessation intervention in all of the smokers at a worksite in Japan.
Ind Health. 2000;38:396-403.
32. Kornitzer M, Dramaix M, Kittel F, De Backer G. The Belgian heart disease
prevention project: changes in smoking habits after two years of intervention.
Prev Med. 1980;9:496-503.
33. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation.
Cochrane Database Syst Rev. 2005;CD001292.
34. Stead LF, Perera R, Lancaster T. Telephone counselling for smoking cessation.
Cochrane Database Syst Rev. 2006;3:CD002850.
35. An LC, Schillo BA, Kavanaugh AM, et al. Increased reach and effectiveness
of a statewide tobacco quitline after the addition of access to free nicotine
replacement therapy. Tob Control. 2006;15:286-293.
36. Macleod ZR, Charles MA, Arnaldi VC, Adams IM. Telephone counselling as an
adjunct to nicotine patches in smoking cessation: a randomised controlled trial.
Med J Aust. 2003;179:349-352.
37. Zhu SH, Tedeschi G, Anderson CM, et al. Telephone counseling as adjuvant
treatment for nicotine replacement therapy in a "real-world" setting.
Prev Med. 2000;31:357-363.
38. Fiore MC, Novotny TE, Pierce JP, et al. Methods used to quit smoking in the
United States. Do cessation programs help? JAMA. 1990;263:2760-2765.
39. Chapman S. Stop-smoking clinics: a case for their abandonment. Lancet. 1985;1:918-920.
40. Jason LA, McMahon SD, Salina D, et al. Assessing a Smoking Cessation Intervention
Involving Groups, Incentives, and Self-Help Manuals. Behavior Therapy. 1995;26:393-408.
41. Jason LA, Salina D, McMahon SD, Hedeker D, Stockton M. A worksite smoking
intervention: a 2 year assessment of groups, incentives and self-help. Health
Educ Res. 1997;12:129-138.
42. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of
nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.
Prev Med. 1995;24:41-47.
43. Sutton S, Hallett R. Randomized trial of brief individual treatment for smoking
using nicotine chewing gum in a workplace setting. Am J Public Health. 1987;77:1210-1211.
44. Sutton S, Hallett R. Smoking intervention in the workplace using videotapes
and nicotine chewing gum. Prev Med. 1988;17:48-59.
45. Rodriguez-Artalejo F, Lafuente UP, Guallar-Castillon P, et al. One year effectiveness
of an individualised smoking cessation intervention at the workplace: a randomised
controlled trial. Occup Environ Med. 2003;60:358-363.
46. Hughes JR. Combining behavioral therapy and pharmacotherapy for smoking cessation:
an update. NIDA Res Monogr. 1995;150:92-109.
47. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4-beta2 nicotinic
acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo
for smoking cessation: a randomized controlled trial. JAMA. 2006;296:47-55.
48. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4-beta2
nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release
bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56-63.
49. Serra C, Cabezas C, Bonfill X, Pladevall-Vila M. Interventions for preventing
tobacco smoking in public places. Cochrane Database Syst Rev. 2000;CD001294.
50. US Department of Health and Human Services. National Survey of Worksite Health
Promotion Activities. Final Report. Washington, DC: US Government Printing Office;
1992.
51. American Cancer Society. Smoking in the workplace. Available at: http://www.cancer.org/docroot/PED/content/PED_10_2X_Smoking_In_The_Workplace.asp.
Accessed September 13, 2006.
52. American Nonsmokers' Rights Foundation. States and municipalities with 100%
smokefree laws in workplaces, restaurants, or bars currently in effect as of
July 1, 2006. Available at: Available at: www.no-smoke.org/pdf/100ordlist.pdf.
Accessed August 10, 2006.
53. Lee DJ, LeBlanc W, Fleming LE, Gomez-Marin O, Pitman T. Trends in US smoking
rates in occupational groups: the National Health Interview Survey 1987-1994.
J Occup Environ Med. 2004;46:538-548.
54. Penner M, Penner S. Excess insured health care costs from tobacco-using employees
in a large group plan. J Occup Med. 1990;32:521-523.
55. Kristein MM. How much can business expect to profit from smoking cessation?
Prev Med. 1983;12:358-381.
56. Musich S, Napier D, Edington DW. The association of health risks with workers'
compensation costs. J Occup Environ Med. 2001;43:534-541.
57. Ducatman AM, McLellan RK. Epidemiologic basis for an occupational and environmental
policy on environmental tobacco smoke. J Occup Environ Med. 2000;42:1137-1141.
58. Hammond SK, Sorensen G, Youngstrom R, Ockene JK. Occupational exposure to
environmental tobacco smoke. JAMA. 1995;274:956-960.
59. Becker DM, Conner HF, Waranch HR, et al. The impact of a total ban on smoking
in the Johns Hopkins Children's Center. JAMA. 1989;262:799-802.
60. Borland R, Chapman S, Owen N, Hill D. Effects of workplace smoking bans on
cigarette consumption. Am J Public Health. 1990;80:178-180.
61. Borland R, Owen N, Hocking B. Changes in smoking behaviour after a total
workplace smoking ban. Aust J Public Health. 1991;15:130-134.
62. Centers for Disease Control and Prevention. Evaluation of an employee smoking
policy--Pueblo, Colorado, 1989-90. MMWR Morb Mortal Wkly Rep. 1990;39:673-676.
63. Millar WJ. Evaluation of the impact of smoking restrictions in a government
work setting. Can J Public Health. 1988;79:379-382.
64. Stave GM, Jackson GW. Effect of a total work-site smoking ban on employee
smoking and attitudes. J Occup Med. 1991;33:884-890.
65. Tsushima WT, Shimizu AA. Effects of a no-smoking policy upon medical center
employees. Int J Addict. 1991;26:23-28.
66. Gottlieb NH, Eriksen MP, Lovato CY, Weinstein RP, Green LW. Impact of a restrictive
work site smoking policy on smoking behavior, attitudes, and norms. J Occup Med.
1990;32:16-23.
67. Chapman S, Borland R, Scollo M, Brownson RC, Dominello A, Woodward S. The
impact of smoke-free workplaces on declining cigarette consumption in Australia
and the United States. Am J Public Health. 1999;89:1018-1023.
68. Mullooly JP, Schuman KL, Stevens VJ, Glasgow RE, Vogt TM. Smoking behavior
and attitudes of employees of a large HMO before and after a work site ban on
cigarette smoking. Public Health Rep. 1990;105:623-628.
69. Hudzinski LG, Frohlich ED. One-year longitudinal study of a no-smoking policy
in a medical institution. Chest. 1990;97:1198-1202.
70. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour:
systematic review. BMJ. 2002;325:188-194.
71. Bauer JE, Hyland A, Li Q, Steger C, Cummings KM. A longitudinal assessment
of the impact of smoke-free worksite policies on tobacco use. Am J Public Health.
2005;95:1024-1029.
72. Mausner B. An ecological view of cigarette smoking. J Abnorm Psychol. 1973;31:115-126.
73. Eisinger RA. Psychosocial predictors of smoking behavior change. Soc Sci
Med. 1972;6:137-144.
74. Olsen GW, Shellenberger RJ, Lacy SE, Fishbeck WA, Bond GG. A smoking cessation
incentive program for chemical employees: design and evaluation. Am J Prev Med.
1990;6:200-207.
75. Glasgow RE, Hollis JF, Ary DV, Boles SM. Results of a year-long incentives-based
worksite smoking-cessation program. Addict Behav. 1993;18:455-464.
76. Rand CS, Stitzer ML, Bigelow GE, Mead AM. The effects of contingent payment
and frequent workplace monitoring on smoking abstinence. Addict Behav. 1989;14:121-128.
77. Windsor RA, Lowe JB. Behavioral impact and cost analysis of a worksite self-help
smoking cessation program. Prog Clin Biol Res. 1989;293:231-242.
78. Hennrikus DJ, Jeffery RW, Lando HA, et al. The SUCCESS project: the effect
of program format and incentives on participation and cessation in worksite smoking
cessation programs. Am J Public Health. 2002;92:274-279.
79. Hey K, Perera R. Quit and Win contests for smoking cessation. Cochrane Database
Syst Rev. 2005;CD004986.
80. Cox JL, McKenna JP. Nicotine gum: does providing it free in a smoking cessation
program alter success rates? J Fam Pract. 1990;31:278-280.
81. Hughes JR, Wadland WC, Fenwick JW, Lewis J, Bickel WK. Effect of cost on
the self-administration and efficacy of nicotine gum: a preliminary study. Prev
Med. 1991;20:486-496.
82. Curry SJ, Grothaus LC, McAfee T, Pabiniak C. Use and cost effectiveness of
smoking-cessation services under four insurance plans in a health maintenance
organization. N Engl J Med. 1998;339:673-679.
83. Shipley RH, Orleans CT, Wilbur CS, Piserchia PV, McFadden DW. Effect of the
Johnson & Johnson Live for Life program on employee smoking. Prev Med. 1988;17:25-34.
84. Dawley HH, Jr., Dawley LT, Correa P, Fleischer B. A comprehensive worksite
smoking control, discouragement, and cessation program. Int J Addict. 1991;26:685-696.
85. Shi L. The impact of increasing intensity of health promotion intervention
on risk reduction. Eval Health Prof. 1992;15:3-25.
86. Nilsson PM, Klasson EB, Nyberg P. Life-style intervention at the worksite--reduction
of cardiovascular risk factors in a randomized study. Scand J Work Environ Health.
2001;27:57-62.
87. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change.
Am J Health Promot. 1997;12:38-48.
88. Hallett R, Sutton SR. Predicting participation and outcome in four workplace
smoking intervention programs. Health Educ Res. 1987;2:257-266.
89. Office of the US Surgeon General. The Health Benefits of Smoking Cessation:
A report of the Surgeon General. Atlanta, Ga: US Dept of Health and Human Services;
1990.
90. Velicer WF, Prochaska JO, Fava JL, Laforge RG, Rossi JS. Interactive versus
noninteractive interventions and dose-response relationships for stage-matched
smoking cessation programs in a managed care setting. Health Psychol. 1999;18:21-28.
91. Hooten WM, Ames SC, Vickers KS, et al. Personality correlates related to
tobacco abstinence following treatment. Int J Psychiatry Med. 2005;35:59-74.
92. Benowitz NL. Nicotine addiction. Prim Care. 1999;26:611-631.
93. Rose JE, Behm FM, Westman EC, Johnson M. Dissociating nicotine and nonnicotine
components of cigarette smoking. Pharmacol Biochem Behav. 2000;67:71-81.
94. Osinubi OY, Sinha S, Rovner E, et al. Efficacy of tobacco dependence treatment
in the context of a "smoke-free grounds" worksite policy: a case study.
Am J Ind Med. 2004;46:180-187.
95. Fisher EB, Jr., Bishop DB, Levitt-Gilmour T, Cappello MT, Ashenberg ZS, Newman
E. Social support in worksite smoking cessation: qualitative analysis of the
EASE project. Am J Health Promot. 1994;9:39-47, 75.
96. Pierce JP, Gilpin EA. A minimum 6-month prolonged abstinence should be required
for evaluating smoking cessation trials. Nicotine Tob Res. 2003;5:151-153.
97. Yudkin P, Hey K, Roberts S, Welch S, Murphy M, Walton R. Abstinence from
smoking eight years after participation in randomised controlled trial of nicotine
patch. BMJ. 2003;327:28-29.
98. Fu SS, Partin MR, Snyder A, et al. Promoting repeat tobacco dependence treatment:
are relapsed smokers interested? Am J Manag Care. 2006;12:235-243.
99. Piasecki TM. Relapse to smoking. Clin Psychol Rev. 2006;26:196-215.
100. Longo DR, Johnson JC, Kruse RL, Brownson RC, Hewett JE. A prospective investigation
of the impact of smoking bans on tobacco cessation and relapse. Tob Control.
2001;10:267-272.
101. Partin MR, An LC, Nelson DB, et al. Randomized trial of an intervention
to facilitate recycling for relapsed smokers. Am J Prev Med. 2006;31:293-299.
102. Goff V. Consumer cost sharing in private health insurance: on the threshold
of change. Issue Brief Natl Health Policy Forum. 2004;798:1-19.
103. Kaper J, Wagena EJ, Willemsen MC, van Schayck CP. Reimbursement for smoking
cessation treatment may double the abstinence rate: results of a randomized trial.
Addiction. 2005;100:1012-1020.
104. US Department of Labor Employee Benefits Security Administration. Compliance
Assistance Guide: Health Benefits Coverage Under Federal Law. Health Insurance
Portability and Accountability Act of 1996. Available at: Available at: http://www.gol.gov/ebsa/pdf/CAGTTableOfContents/.pdf.
Accessed October 21, 2006.
105. Jeffery RW, Forster JL, French SA, et al. The Healthy Worker Project: a
work-site intervention for weight control and smoking cessation. Am J Public
Health. 1993;83:395-401.
106. Levy DE. Employer-sponsored insurance coverage of smoking cessation treatments.
Am J Manag Care. 2006;12:553-562. |
